Ali Rezai
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of FUS neuromodulation in patients with Binge Eating Disorder (BED)
The primary objective is to evaluate the safety, feasibility and tolerability of FUS as an adjunct neuromodulatory treatment for BED
A candidate will be eligible if they meet all the following criteria: * Age 18-80 years at time of enrollment. * Diagnosis of moderate to extreme binge eating disorder (BED) per DSM-5-TR criteria * Participant is able and willing to give informed consent. * Participant is willing to cooperate with the study requirements, including compliance with the regimen, completion of all study visits, and study assessments. * Participants of reproductive potential must have negative pregnancy test and agree to use acceptable forms of contraception. * Participant able to communicate sensations during the…
Subjects will undergo a single LIFU of the target brain region
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.